Back to GetFilings.com



Table of Contents

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

x Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

 

For the quarterly period ended March 31, 2004

 

or

 

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from                      to                     

 

Commission file number: 0-24260

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   11-3131700

(State or Other Jurisdiction of

Incorporation or Organization)

  (I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

Number of shares of Common Stock, par value $.001, outstanding as of May 10, 2004: 12,305,943 shares

 


 

1


Table of Contents
    

PART I.

FINANCIAL INFORMATION

    

Item 1.

  

Financial Statements

    
    

Consolidated Balance Sheets as of March 31, 2004 and December 31, 2003

   3
    

Consolidated Statements of Operations for the Three Months Ended March 31, 2004 and 2003

   4
    

Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2004 and 2003

   5
    

Notes to Consolidated Financial Statements

   6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   16

Item 3.

  

Quantitative and Qualitative Disclosures about Market Risks

   25

Item 4.

  

Controls and Procedures

   25
    

PART II.

OTHER INFORMATION

    

Item 1.

  

Legal Proceedings

   25

Item 2.

  

Changes in Securities and Use of Proceeds

   25

Item 3.

  

Defaults Upon Senior Securities

   25

Item 4.

  

Submission of Matters to a Vote of Security Holders

   26

Item 5.

  

Other Information

   26

Item 6.

  

Exhibits and Reports on Form 8-K

   26

 

2


Table of Contents
Item 1. FINANCIAL STATEMENTS

 

AMEDISYS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

As of March 31, 2004 and December 31, 2003

(Dollar amounts in 000’s, except share data)

 

     March 31, 2004

    December 31, 2003

 

ASSETS:

     (unaudited )        

CURRENT ASSETS:

                

Cash and cash equivalents

   $ 24,338     $ 29,779  

Patient accounts receivable, net of allowance for doubtful accounts

                

of $3,554 at March 31, 2004 and $3,008 at December 31, 2003

     14,893       15,185  

Prepaid expenses

     2,452       1,103  

Deferred income taxes

     831       1,650  

Inventory and other current assets

     1,269       1,879  
    


 


Total current assets

     43,783       49,596  

Property and equipment, net

     7,239       7,219  

Goodwill and other assets, net

     55,106       35,658  
    


 


Total assets

   $ 106,128     $ 92,473  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY:

                

CURRENT LIABILITIES:

                

Accounts payable

   $ 5,009     $ 3,340  

Accrued expenses:

                

Payroll and payroll taxes

     10,639       9,163  

Insurance

     1,990       2,336  

Income taxes

     735       575  

Legal settlements

     1,337       1,248  

Other

     7,985       2,818  

Current portion of long-term debt

     4,175       3,974  

Current portion of obligations under capital leases

     653       1,217  

Current portion of Medicare liabilities

     9,350       9,347  
    


 


Total current liabilities

     41,873       34,018  

Long-term debt

     1,807       2,696  

Obligations under capital leases

     391       391  

Deferred income taxes

     3,264       2,756  

Other long-term liabilities

     1,213       1,213  
    


 


Total liabilities

     48,548       41,074  

STOCKHOLDERS’ EQUITY:

                

Preferred stock, $.001 par value, 5,000,000 shares authorized;

                

None issued and outstanding

     —         —    

Common stock, $.001 par value, 30,000,000 shares authorized;

                

12,146,898 and 11,908,146 shares issued at March 31, 2004 and

December 31, 2003, respectively

     12       12  

Additional paid-in capital

     57,425       55,465  

Treasury stock at cost, 4,167 shares held

     (25 )     (25 )

Retained earnings (deficit)

     168       (4,053 )
    


 


Total stockholders’ equity

     57,580       51,399  
    


 


Total liabilities and stockholders’ equity

   $ 106,128     $ 92,473  
    


 


 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

AMEDISYS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

For the three months ended March 31, 2004 and 2003

(dollar amounts in 000’s, except per share data)

 

     For the three months ended
March 31,


 
     2004

    2003

 
     (unaudited)     (unaudited)  

Income:

                

Net service revenue

   $ 47,339     $ 31,132  

Cost of service revenue (excluding depreciation and amortization)

     19,480       12,909  
    


 


Gross margin

     27,859       18,223  
    


 


General and administrative expenses:

                

Salaries and benefits

     12,557       9,861  

Other

     8,397       6,178  
    


 


Total general and administrative expenses

     20,954       16,039  
    


 


Operating income

     6,905       2,184  

Other income (expense):

                

Interest income

     52       17  

Interest expense

     (124 )     (360 )

Miscellaneous

     (4 )     10  
    


 


Total other expense, net

     (76 )     (333 )
    


 


Income before income taxes

     6,829       1,851  

Income tax expense

     2,608       702  
    


 


Net income

   $ 4,221     $ 1,149  
    


 


Basic weighted average common shares outstanding

     12,006,000       9,327,000  

Basic income per common share:

                
    


 


Net income

   $ 0.35     $ 0.12  
    


 


Diluted weighted average common shares outstanding

     12,536,000       9,501,000  

Diluted income per common share:

                
    


 


Net income

   $ 0.34     $ 0.12  
    


 


 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

AMEDISYS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2004 and 2003

(Unaudited, Dollar amounts in 000’s)

 

     Three months ended

 
     March 31, 2004

    March 31, 2003

 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income

   $ 4,221     $ 1,149  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation

     894       740  

Provision for bad debts

     743       494  

Deferred income taxes

     1,327       660  

Tax benefit from stock option exercises

     880       9  

Compensation expense

     20       —    

Changes in assets and liabilities:

                

(Increase) decrease in accounts receivable

     (451 )     2,746  

(Increase) in inventory and other current assets

     (719 )     (564 )

(Increase) decrease in other assets

     (470 )     20  

Increase (decrease) in accounts payable

     1,670       (719 )

Increase (decrease) in Medicare liabilities

     4       (116 )

Increase in accrued expenses

     1,614       317  
    


 


Net cash provided by operating activities

     9,733       4,736  
    


 


CASH FLOWS FROM INVESTING ACTIVITIES:

                

Proceeds from sale of property and equipment

     9       —    

Purchase of property and equipment

     (625 )     (298 )

Cash used in purchase acquisitions

     (14,151 )     —    
    


 


Net cash used in investing activities

     (14,767 )     (298 )
    


 


CASH FLOWS FROM FINANCING ACTIVITIES:

                

Proceeds from issuance of notes payable

     417       544  

Payments on notes payable and capital leases

     (1,773 )     (1,700 )

Decrease in Medicare liabilities, net

     —         (786 )

Proceeds from private placement of stock, net

     (23 )     —    

Proceeds from issuance of stock from Employee Stock Purchase Plan

     153       531  

Proceeds from issuance of stock upon exercise of stock options and warrants

     819       453  
    


 


Net cash used in financing activities

     (407 )     (958 )
    


 


NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

     (5,441 )     3,840  

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

     29,779       4,861  
    


 


CASH AND CASH EQUIVALENTS AT END OF PERIOD

   $ 24,338     $ 8,341  
    


 


SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

                

Cash paid for:

                

Interest

   $ 109     $ 340  
    


 


Income taxes

   $ 300     $ (151 )
    


 


 

See accompanying notes to consolidated financial statements.

 

5


Table of Contents

AMEDISYS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

 

1. Organization

 

Amedisys, Inc. (“Amedisys” or “the Company”) is a multi-state provider of home health care nursing services. At March 31, 2004, the Company operated ninety-two home care nursing offices and two corporate offices in the southern and southeastern United States.

 

In the opinion of management of the Company, the accompanying unaudited consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the Company’s financial position at March 31, 2004, the results of operations for the three months ended March 31, 2004 and 2003, and cash flows for the three months ended March 31, 2004 and 2003. The results of operations for the interim periods are not necessarily indicative of results of operations for the entire year. These interim consolidated financial statements should be read in conjunction with the Company’s annual financial statements and related notes in the Company’s Form 10-K.

 

2. Revenue Recognition

 

Medicare Revenue Recognition

 

Under the Medicare Prospective Payment System (“PPS”), the Company is paid by Medicare based on episodes of care. An episode of care is defined as a length of care up to sixty days with multiple continuous episodes allowed. A base episode payment is established by the Medicare Program through federal legislation for all episodes of care ended on or after the applicable time periods detailed below:

 

Period


   Base episode payment

Beginning October 1, 2000 through March 31, 2001

   $ 2,115 per episode

April 1, 2001 through September 30, 2001

   $ 2,264 per episode

October 1, 2001 through September 30, 2002

   $ 2,274 per episode

October 1, 2002 through September 30, 2003

   $ 2,159 per episode

October 1, 2003 through March 31, 2004

   $ 2,231 per episode

April 1, 2004 through December 31, 2004

   $ 2,213 per episode

 

With respect to Medicare reimbursement changes, the applicability of the reimbursement change is dependent upon the completion date of the episode; therefore, changes in reimbursement, both positive and negative, will impact the financial results of the Company up to sixty days in advance of the effective date.

 

The base episode payment is adjusted by applicable regulations including, but not limited to, the following: a case mix adjuster consisting of eighty (80) home health resource groups (“HHRG”), the applicable geographic wage index, low utilization (either expected or unexpected), intervening events and other factors. The episode payment is also adjusted in the event that a patient is either readmitted by the Company, or admitted to another home health agency prior to the expiration of 60 days from the original admission date – these adjustments are known as partial episode payments. The episode payment will be made to providers regardless of the cost to provide care. The services covered by the episode payment include all disciplines of care, in addition to medical supplies, within the scope of the home health benefit.

 

A portion of reimbursement from each Medicare episode is billed and cash is typically received before all services are rendered. The estimated episodic payment is billed at the commencement of the episode. Sixty percent of the estimated reimbursement is received at initial billing for the initial episode of c